Literature DB >> 1682739

Erythropoietin and spontaneous platelet aggregation in haemodialysis patients.

J E Taylor1, I S Henderson, W K Stewart, J J Belch.   

Abstract

Erythropoietin significantly, reversibly, and reproducibly increased in-vitro whole-blood spontaneous platelet aggregation in 15 patients on haemodialysis. During erythropoietin treatment, spontaneous platelet aggregation was significantly higher in these subjects than in non-uraemic controls; concomitant treatment with 300 mg aspirin daily reversed platelet hyperaggregability. Erythropoietin may promote thrombosis by an effect on platelet function.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1682739     DOI： 10.1016/0140-6736(91)92239-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions.

Authors:  Katie M Twomley; Sunil V Rao; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

Review 2.  Low-dosage epoetin in maintenance haemodialysis: costs and quality-of-life improvement.

Authors:  D C Harris
Journal:  Pharmacoeconomics       Date:  1994-01       Impact factor: 4.981

Review 3.  Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.

Authors:  R Whittington; L B Barradell; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

Review 4.  [Thrombocytopathy and blood complications in uremia].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2006-04       Impact factor: 1.704

Review 5.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

6.  The effect of erythropoietin on platelet function in uraemic children on haemodialysis.

Authors:  S Turi; J Soos; C Torday; C Bereczki; Z Havass
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

Review 7.  Pharmacological approaches to reduce perioperative transfusion requirements in the aged.

Authors:  T Tasaki; H Ohto; R Motoki
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

Review 8.  Drug-induced cardiovascular disorders.

Authors:  C Aengus Murphy; Henry J Dargie
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  Increase in mean platelet volume in patients with chronic renal failure treated with erythropoietin.

Authors:  P C Sharpe; Z R Desai; T C Morris
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

10.  Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials.

Authors:  Yuqiu Ye; Hongyong Liu; Yanbing Chen; Yunqiang Zhang; Shaomin Li; Wentao Hu; Rongqian Yang; Zhesi Zhang; Linsheng Lv; Xun Liu
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.